|
Total
|
–
|
157 (100%)
|
115 (100%)
|
115 (100%)
|
387 (100%)
|
–
|
|
Journal impact factor (JIF)
|
JIF < 2
|
52 (33.1%)
|
45 (39.1%)
|
79 (68.7%)
|
176 (45.5%)
|
< 0.0001
|
|
2 ≤ JIF < 4
|
62 (39.5%)
|
44 (38.3%)
|
26 (22.6%)
|
132 (34.1%)
|
|
JIF ≥ 4
|
43 (27.4%)
|
26 (22.6%)
|
10 (8.7%)
|
79 (20.4%)
|
|
Yearly number of citations (n)
|
n < 10
|
64 (40.8%)
|
74 (64.3%)
|
83 (72.2%)
|
221 (57.1%)
|
< 0.0001
|
|
10 ≤ n < 50
|
72 (45.9%)
|
35 (30.4%)
|
32 (27.8%)
|
139 (35.9%)
|
|
50 ≤ n < 100
|
12 (7.6%)
|
4 (3.5%)
|
0 (0.0%)
|
16 (4.1%)
|
|
n ≥ 100
|
9 (5.7%)
|
2 (1.7%)
|
0 (0.0%)
|
11 (2.8%)
|
|
Journal access
|
Open
|
59 (37.6%)
|
55 (47.8%)
|
74 (64.3%)
|
188 (48.6%)
|
< 0.0001
|
|
Hybrid
|
80 (51.0%)
|
56 (48.7%)
|
39 (33.9%)
|
175 (45.2%)
|
|
Non-open
|
18 (11.5%)
|
4 (3.5%)
|
2 (1.7%)
|
24 (6.2%)
|
|
Systematic review geographical coverage
|
Country-specific
|
18 (11.5%)
|
30 (26.1%)
|
43 (37.4%)
|
91 (23.5%)
|
< 0.0001
|
|
Global/multiple regions
|
85 (54.1%)
|
19 (16.5%)
|
13 (11.3%)
|
117 (30.2%)
|
|
Middle East and North Africa/ Arab world
|
21 (13.4%)
|
23 (20.0%)
|
29 (25.2%)
|
73 (18.9%)
|
|
Middle East/ Asia/ Gulf Cooperation Council
|
24 (15.3%)
|
22 (19.1%)
|
23 (20.0%)
|
69 (17.8%)
|
|
North Africa/ East Africa/ Africa
|
9 (5.7%)
|
21 (18.3%)
|
7 (6.1%)
|
37 (9.6%)
|
|
Systematic review health topic
|
Alcohol, substance, and nicotine abuses
|
11 (7.0%)
|
2 (1.7%)
|
5 (4.3%)
|
18 (4.7%)
|
NS
|
|
Cardiovascular disease
|
7 (4.5%)
|
6 (5.2%)
|
4 (3.5%)
|
17 (4.4%)
|
|
Diabetes
|
7 (4.5%)
|
8 (7.0%)
|
6 (5.2%)
|
21 (5.4%)
|
|
Other metabolic syndromes
|
5 (3.2%)
|
7 (6.1%)
|
3 (2.6%)
|
15 (3.9%)
|
|
Genetics
|
1 (0.6%)
|
3 (2.6%)
|
5 (4.3%)
|
9 (2.3%)
|
|
Infectious disease
|
46 (29.3%)
|
46 (40.0%)
|
41 (35.7%)
|
133 (34.4%)
|
|
Mental health
|
8 (5.1%)
|
12 (10.4%)
|
8 (7.0%)
|
28 (7.2%)
|
|
Nutrition
|
8 (5.1%)
|
1 (0.9%)
|
5 (4.3%)
|
14 (3.6%)
|
|
Cancer
|
12 (7.6%)
|
4 (3.5%)
|
12 (10.4%)
|
28 (7.2%)
|
|
Other
|
41 (26.1%)
|
24 (20.9%)
|
23 (20.0%)
|
88 (22.7%)
|
|
Trauma/Injury/Violence
|
11 (7.0%)
|
2 (1.7%)
|
3 (2.6%)
|
16 (4.1%)
|
